National Institute for Translational Neuroscience and National Institute of Oncogenomics

São Paulo, Brazil

National Institute for Translational Neuroscience and National Institute of Oncogenomics

São Paulo, Brazil
SEARCH FILTERS
Time filter
Source Type

Lopes M.H.,International Research Center | Lopes M.H.,University of Sao Paulo | Lopes M.H.,National Institute for Translational Neuroscience and National Institute of Oncogenomics | Santos T.G.,International Research Center | And 24 more authors.
Oncogene | Year: 2015

Glioblastomas (GBMs) are resistant to current therapy protocols and identification of molecules that target these tumors is crucial. Interaction of secreted heat-shock protein 70 (Hsp70)-Hsp90-organizing protein (HOP) with cellular prion protein (PrPC) triggers a large number of trophic effects in the nervous system. We found that both PrPC and HOP are highly expressed in human GBM samples relative to non-tumoral tissue or astrocytoma grades I-III. High levels of PrPC and HOP were associated with greater GBM proliferation and lower patient survival. HOP-PrPC binding increased GBM proliferation in vitro via phosphatidylinositide 3-kinase and extracellular-signal-regulated kinase pathways, and a HOP peptide mimicking the PrPC binding site (HOP 230-245) abrogates this effect. PrPC knockdown impaired tumor growth and increased survival of mice with tumors. In mice, intratumor delivery of HOP 230-245 peptide impaired proliferation and promoted apoptosis of GBM cells. In addition, treatment with HOP 230-245 peptide inhibited tumor growth, maintained cognitive performance and improved survival. Thus, together, the present results indicate that interfering with PrPC -HOP engagement is a promising approach for GBM therapy. © 2015 Macmillan Publishers Limited.

Loading National Institute for Translational Neuroscience and National Institute of Oncogenomics collaborators
Loading National Institute for Translational Neuroscience and National Institute of Oncogenomics collaborators